Phase I study of 21 days continuous infusion with vindesine.
作者信息
de Vries E G, Smit E F, Vendrig D E, Holthuis J J, Mulder N H
机构信息
Department of Internal Medicine, University Hospital Groningen, The Netherlands.
出版信息
Br J Cancer. 1989 Mar;59(3):471-2. doi: 10.1038/bjc.1989.97.
Abstract
摘要
相似文献
1
Phase I study of 21 days continuous infusion with vindesine.长春地辛持续输注21天的I期研究。
Br J Cancer. 1989 Mar;59(3):471-2. doi: 10.1038/bjc.1989.97.
2
Continuous-infusion vindesine in refractory carcinoma of the cervix: a phase II trial.
Cancer Treat Rep. 1985 Nov;69(11):1317-8.
3
Continuous venous infusion of vindesine in metastatic breast cancer: experience with a subcutaneously implanted system and portable pump.
Anticancer Res. 1989 Jan-Feb;9(1):141-3.
4
5
Phase one study of twice-weekly vindesine.
Eur J Cancer Clin Oncol. 1985 Dec;21(12):1555-6. doi: 10.1016/0277-5379(85)90252-4.
6
Twice weekly vindesine, a phase II study in lung cancer.
J Cancer Res Clin Oncol. 1987;113(1):99-100. doi: 10.1007/BF00389975.
7
Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
Cancer Treat Rep. 1984 Sep;68(9):1199-200.
8
9
Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion.
Cancer Treat Rep. 1981 Sep-Oct;65(9-10):775-9.
10
[A phase II study of vindesine for pretreated non-small cell lung cancer].
Gan To Kagaku Ryoho. 1987 Aug;14(8):2532-6.
本文引用的文献
1
Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion.
Cancer Treat Rep. 1981 Sep-Oct;65(9-10):775-9.
2
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.顺铂与长春地辛联合化疗治疗晚期肺癌：一项比较两种给药方案的随机试验。
Ann Intern Med. 1981 Oct;95(4):414-20. doi: 10.7326/0003-4819-95-4-414.
3
Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion.长春新碱输注治疗晚期非霍奇金淋巴瘤
Cancer. 1984 Jun 15;53(12):2601-6. doi: 10.1002/1097-0142(19840615)53:12<2601::aid-cncr2820531205>3.0.co;2-d.
4
Protracted vinblastine infusion. Phase I-II study in malignant melanoma and other tumors.
Am J Clin Oncol. 1984 Oct;7(5):551-3.
5
Pharmacokinetics of vindesine bolus and infusion.
Cancer Chemother Pharmacol. 1984;13(2):114-9. doi: 10.1007/BF00257126.
6
Continuous infusion or bolus injection in cancer chemotherapy.
Ann Intern Med. 1983 Dec;99(6):823-33. doi: 10.7326/0003-4819-99-6-823.
7
Evaluation of a totally implanted venous access port and portable pump in a continuous chemotherapy infusion schedule on an outpatient basis.门诊连续化疗输注方案中完全植入式静脉通路端口和便携式泵的评估。
Eur J Cancer Clin Oncol. 1987 Nov;23(11):1653-7. doi: 10.1016/0277-5379(87)90445-7.
8
A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin.一项表柔比星21天持续输注的I期药代动力学研究。
J Clin Oncol. 1987 Sep;5(9):1445-51. doi: 10.1200/JCO.1987.5.9.1445.
9
Analysis of vinca alkaloids in plasma and urine using high-performance liquid chromatography with electrochemical detection.
J Chromatogr. 1988 Jan 22;424(1):83-94. doi: 10.1016/s0378-4347(00)81078-6.
10
Clinical pharmacokinetics of vindesine infusion.
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):839-44.
Zotero 插件